Shimoyama S, Nakagawa I, Jiang J, Matsumoto I, Chiorini J, Hasegawa Y
Int Immunol. 2021; 33(8):423-434.
PMID: 34036345
PMC: 8299718.
DOI: 10.1093/intimm/dxab025.
Del Corvo M, Luini M, Stella A, Pagnacco G, Ajmone-Marsan P, Williams J
Mamm Genome. 2017; 28(11-12):520-527.
PMID: 28864882
DOI: 10.1007/s00335-017-9714-7.
Bridges R, Sohn S, Wright J, Leppard K, Hearing P
mBio. 2016; 7(1):e02184-15.
PMID: 26814176
PMC: 4742714.
DOI: 10.1128/mBio.02184-15.
Pena-Hernandez R, Marques M, Hilmi K, Zhao T, Saad A, Alaoui-Jamali M
Proc Natl Acad Sci U S A. 2015; 112(7):E677-86.
PMID: 25646466
PMC: 4343169.
DOI: 10.1073/pnas.1416674112.
Ghosh S, Adhikary A, Chakraborty S, Bhattacharjee P, Mazumder M, Putatunda S
J Biol Chem. 2014; 290(7):3936-49.
PMID: 25527500
PMC: 4326803.
DOI: 10.1074/jbc.M114.594028.
Genomic and proteomic analysis of transcription factor TFII-I reveals insight into the response to cellular stress.
Fan A, Papadopoulos G, Hossain M, Lin I, Hu J, Tang T
Nucleic Acids Res. 2014; 42(12):7625-41.
PMID: 24875474
PMC: 4081084.
DOI: 10.1093/nar/gku467.
CD147 induces UPR to inhibit apoptosis and chemosensitivity by increasing the transcription of Bip in hepatocellular carcinoma.
Tang J, Guo Y, Zhang Y, Yu X, Li L, Huang W
Cell Death Differ. 2012; 19(11):1779-90.
PMID: 22595757
PMC: 3469060.
DOI: 10.1038/cdd.2012.60.
Biochemistry and biology of the inducible multifunctional transcription factor TFII-I: 10 years later.
Roy A
Gene. 2011; 492(1):32-41.
PMID: 22037610
PMC: 3246126.
DOI: 10.1016/j.gene.2011.10.030.
Direct interactions of OCA-B and TFII-I regulate immunoglobulin heavy-chain gene transcription by facilitating enhancer-promoter communication.
Ren X, Siegel R, Kim U, Roeder R
Mol Cell. 2011; 42(3):342-55.
PMID: 21549311
PMC: 3105350.
DOI: 10.1016/j.molcel.2011.04.011.
Role of helix-loop-helix proteins during differentiation of erythroid cells.
Anantharaman A, Lin I, Barrow J, Liang S, Masannat J, Strouboulis J
Mol Cell Biol. 2011; 31(7):1332-43.
PMID: 21282467
PMC: 3135301.
DOI: 10.1128/MCB.01186-10.
Role for transcription factor TFII-I in the suppression of SSeCKS/Gravin/Akap12 transcription by Src.
Bu Y, Gao L, Gelman I
Int J Cancer. 2010; 128(8):1836-42.
PMID: 20568114
PMC: 2997892.
DOI: 10.1002/ijc.25524.
Characterization of a novel interaction between transcription factor TFII-I and the inducible tyrosine kinase in T cells.
Sacristan C, Schattgen S, Berg L, Bunnell S, Roy A, Rosenstein Y
Eur J Immunol. 2009; 39(9):2584-95.
PMID: 19701889
PMC: 3014647.
DOI: 10.1002/eji.200839031.
Signal-induced functions of the transcription factor TFII-I.
Roy A
Biochim Biophys Acta. 2007; 1769(11-12):613-21.
PMID: 17976384
PMC: 2140948.
DOI: 10.1016/j.bbaexp.2007.10.002.
Inhibition of TFII-I-dependent cell cycle regulation by p53.
Desgranges Z, Ahn J, Lazebnik M, Ashworth T, Lee C, Pestell R
Mol Cell Biol. 2005; 25(24):10940-52.
PMID: 16314517
PMC: 1316948.
DOI: 10.1128/MCB.25.24.10940-10952.2005.
Phosphoproteome profiling of transforming growth factor (TGF)-beta signaling: abrogation of TGFbeta1-dependent phosphorylation of transcription factor-II-I (TFII-I) enhances cooperation of TFII-I and Smad3 in transcription.
Stasyk T, Dubrovska A, Lomnytska M, Yakymovych I, Wernstedt C, Heldin C
Mol Biol Cell. 2005; 16(10):4765-80.
PMID: 16055503
PMC: 1237082.
DOI: 10.1091/mbc.e05-03-0257.
Bruton's tyrosine kinase regulates immunoglobulin promoter activation in association with the transcription factor Bright.
Rajaiya J, Hatfield M, Nixon J, Rawlings D, Webb C
Mol Cell Biol. 2005; 25(6):2073-84.
PMID: 15743806
PMC: 1061591.
DOI: 10.1128/MCB.25.6.2073-2084.2005.
The transcription factor, Bright, and immunoglobulin heavy chain expression.
WEBB C
Immunol Res. 2001; 24(2):149-61.
PMID: 11594453
DOI: 10.1385/IR:24:2:149.
JAK2 activates TFII-I and regulates its interaction with extracellular signal-regulated kinase.
Kim D, Cochran B
Mol Cell Biol. 2001; 21(10):3387-97.
PMID: 11313464
PMC: 100260.
DOI: 10.1128/MCB.21.10.3387-3397.2000.
Identification of TFII-I as the endoplasmic reticulum stress response element binding factor ERSF: its autoregulation by stress and interaction with ATF6.
Parker R, Phan T, Baumeister P, Roy B, Cheriyath V, Roy A
Mol Cell Biol. 2001; 21(9):3220-33.
PMID: 11287625
PMC: 86961.
DOI: 10.1128/MCB.21.9.3220-3233.2001.
The Rous sarcoma virus long terminal repeat promoter is regulated by TFII-I.
Mobley C, Sealy L
J Virol. 2000; 74(14):6511-9.
PMID: 10864664
PMC: 112160.
DOI: 10.1128/jvi.74.14.6511-6519.2000.